STOCK TITAN
  1. Home
  2. Sec-filings
  3. STOK
  4. [EFFECT] Stoke Therapeutics, Inc. SEC Filing

[EFFECT] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001623526
Company Name: Stoke Therapeutics, Inc.
File Number: 333-288583

Source: View Original Filing on SEC EDGAR

Stock STOK logo
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

#4481 Ranked by Market Cap
N/A Ranked by Dividends
#18 Top Loser

STOK Latest News

Jun 17, 2025
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 29, 2025
Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference
May 13, 2025
Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
Apr 1, 2025
Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
Mar 18, 2025
Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

STOK Latest SEC Filings

Jul 10, 2025
[8-K] Stoke Therapeutics, Inc. Reports Material Event
Jul 9, 2025
[S-8] Stoke Therapeutics, Inc. Employee Benefit Plan Registration
Jul 9, 2025
[S-3] Stoke Therapeutics, Inc. Shelf Registration Statement
Jul 2, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity
Jul 2, 2025
[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity

STOK Stock Data

638.24M
52.07M
4.67%
110.52%
21.1%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD